Last reviewed · How we verify

NCT03525951

Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes

Completed NA Last updated 13 November 2025
What this trial tests

NA trial testing Enhanced Milieu Teaching in Language Development Disorders in 156 participants. Completed in 18 September 2025.

Timeline
22 March 2021
Primary endpoint
18 September 2025
18 September 2025

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment156
Start date22 March 2021
Primary completion18 September 2025
Estimated completion18 September 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

30 Months and older, any sex, with Language Development Disorders or Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Children with poor early language skills are at risk for academic, social, vocational, and health difficulties across the lifespan. Parent training-as part of early language intervention-is a cost-effective option to address this public health issue, but these interventions demonstrate large individual differences in outcomes and barriers to scalability. The purpose of this research is to examine parent-level predictors of early language interaction quality and modifiability during training, which will help increase intervention effectiveness.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Enhanced Milieu Teaching

Trials testing the same drug.

Other recruiting trials for Language Development Disorders

Currently open trials in the same condition.

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing